Medicare Enrolled

Dr. Emmalind Aponte, MD

Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5206 RESEARCH DR, San Antonio, TX 78240
2105955300
In practice since 2007 (18 years)
NPI: 1699985002 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aponte from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aponte? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aponte

Dr. Emmalind Aponte is a hematology & oncology specialist in San Antonio, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Aponte performed 42,743 Medicare services across 2,322 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aponte received a total of $9,434 from 50 pharmaceutical and/or device companies across 401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aponte is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 23% volume in TX $9,434 industry payments

Medicare Practice Summary

Medicare Utilization ↗
42,743
Medicare services
Top 23% in TX for hematology & oncology
2,322
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,375 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Darbepoetin injection (Aranesp) for anemia 12,310 $2 $20
Azacitidine chemotherapy injection 9,550 $0 $13
Anti-nausea injection (fosaprepitant) 6,600 $0 $5
Contrast dye for imaging (iodine-based) 4,768 $0 $3
Denosumab injection (Prolia/Xgeva) 1,260 $18 $66
Dexamethasone injection (steroid) 1,064 $0 $1
Blood draw (venipuncture) 768 $8 $20
Complete blood count (CBC) with differential 694 $8 $36
Injection, granisetron hydrochloride, 100 mcg 690 $0 $24
Comprehensive metabolic blood panel 612 $10 $64
Anti-nausea injection (Aloxi/palonosetron) 600 $1 $114
Office visit, established patient (20-29 min) 539 $64 $250
Flow cytometry, additional marker 514 $17 $180
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg 252 $82 $1,348
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 221 $22 $157
Office visit, established patient (30-39 min) 179 $89 $368
Administration of chemotherapy into vein, 1 hour or less 178 $95 $707
Measurement of immunoglobulin light chains 140 $16 $60
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 120 $54 $211
Injection, zoledronic acid, 1 mg 118 $6 $431
Ferritin level test (iron stores) 103 $13 $60
Lactate dehydrogenase (enzyme) level 102 $6 $31
Iron level test 98 $6 $27
Iron binding capacity test 98 $8 $35
Drug injection, under skin or into muscle 95 $10 $96
Red blood count automated, with additional calculations 94 $5 $26
Microscopic examination for white blood cells with manual cell count 88 $4 $22
Complete blood count (CBC), automated 88 $6 $34
Vitamin B-12 level test 75 $15 $76
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 72 $46 $313
Hospital follow-up visit, moderate complexity 70 $59 $247
New patient office visit (45-59 min) 68 $118 $565
Injection of additional new drug or substance into vein 59 $11 $108
Administration of additional new drug or substance into vein, 1 hour or less 56 $49 $344
Injection, diphenhydramine hcl, up to 50 mg 55 $1 $7
Reticulated (young) platelet measurement 50 $35 $143
Ct scan of chest with contrast 42 $45 $821
Hospital follow-up visit, high complexity 42 $91 $357
CT scan of abdomen and pelvis with contrast 40 $165 $1,067
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 27 $14 $100
Irrigation of implanted venous access drug delivery device 22 $18 $114
Application of on-body injector for under skin injection 21 $14 $96
Flow cytometry technique for dna or cell analysis, first marker 20 $53 $298
Infusion into a vein for hydration, 31-60 minutes 15 $23 $256
Folic acid level test 14 $14 $73
Protein measurement, serum 14 $11 $99
Initial hospital admission, moderate complexity 14 $100 $470
Immunologic analysis technique on serum (immunofixation) 13 $22 $160
Ct scan for measuring calcium and other minerals in bone 11 $92 $447
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
88.5% medium
10.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,434
Total received (2018-2024)
Avg $1,348/year across 7 years
Top 33% in TX for hematology & oncology
50
Companies
401
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,232 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$202 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$784
2023
$967
2022
$360
2021
$133
2020
$527
2019
$2,364
2018
$4,299

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$757
E.R. Squibb & Sons, L.L.C.
$732
AstraZeneca Pharmaceuticals LP
$675
Myriad Genetic Laboratories, Inc.
$658
Janssen Biotech, Inc.
$650
Amgen Inc.
$648
Takeda Pharmaceuticals U.S.A., Inc.
$634
PFIZER INC.
$347
Genentech USA, Inc.
$345
Incyte Corporation
$342
AbbVie, Inc.
$291
Merck Sharp & Dohme Corporation
$279
Janssen Pharmaceuticals, Inc
$264
Bayer HealthCare Pharmaceuticals Inc.
$183
Seattle Genetics, Inc.
$169
GENZYME CORPORATION
$155
Astellas Pharma US Inc
$150
Gilead Sciences, Inc.
$149
Exelixis Inc.
$141
Ipsen Biopharmaceuticals, Inc
$140
Agios Pharmaceuticals, Inc.
$139
EMD Serono, Inc.
$134
Pharmacyclics LLC, An AbbVie Company
$129
Genmab U.S., Inc.
$125
Bayer Healthcare Pharmaceuticals Inc.
$125
G1 Therapeutics, Inc.
$125
TESARO, Inc.
$102
Merck Sharp & Dohme LLC
$101
Lilly USA, LLC
$98
Verastem, Inc.
$89
Alexion Pharmaceuticals, Inc.
$63
Eisai Inc.
$57
Celgene Corporation
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Jazz Pharmaceuticals Inc.
$42
Apellis Pharmaceuticals, Inc.
$30
Daiichi Sankyo Inc.
$29
Otsuka America Pharmaceutical, Inc.
$29
Clovis Oncology, Inc.
$26
SANOFI PASTEUR INC.
$24
JAZZ PHARMACEUTICALS INC.
$22
ARRAY BIOPHARMA INC
$21
Regeneron Healthcare Solutions, Inc.
$17
INSYS Therapeutics Inc
$17
Helsinn Therapeutics (U.S.), Inc.
$16
Medtronic USA, Inc.
$15
Novo Nordisk Inc
$15
Spectrum Pharmaceuticals Inc.
$13
AMAG Pharmaceuticals, Inc.
$12
Sandoz Inc.
$11
Top 3 companies account for 22.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALOXI · Aliqopa · Avastin · BRACAnalysis · Balversa · Bavencio · Blincyto · CABLIVI · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELITEK · EMEND · EMPLICITI · EXKIVITY · Empaveli · Epkinly · Erleada · FERAHEME · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FRUZAQLA · Folotyn · GILOTRIF · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · MEKINIST · MYCHOICE CDX · MYLOTARG · MYRISK · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · Onivyde · Ozempic · PIQRAY · PRECISETUMOR · PROMACTA · Perjeta · RETEVMO · RYDAPT · Revlimid · Rubraca · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TIBSOVO · Trodelvy · ULTOMIRIS · VENCLEXTA · VOTRIENT · VYXEOS · Vectibix · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xofigo · ZARXIO · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $22 per 100 Medicare services performed
Looking for a hematology & oncology specialist in San Antonio?
Compare hematology & oncology specialists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Aponte is a mixed practice specialist, with above-average Medicare volume (top 23% in TX), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Aponte experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Aponte performed 12,310 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aponte receive payments from pharmaceutical companies?
Yes. Dr. Aponte received a total of $9,434 from 50 companies across 401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aponte's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Aponte's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aponte) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →